71 filings
8-K
GH
Guardant Health Inc
22 Mar 24
Departure of Directors or Certain Officers
5:10pm
8-K
GH
Guardant Health Inc
22 Feb 24
Guardant Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook
4:10pm
8-K
GH
Guardant Health Inc
1 Feb 24
Departure of Directors or Certain Officers
4:20pm
8-K
GH
Guardant Health Inc
8 Jan 24
Guardant Health Announces Preliminary Fourth Quarter and Full Year 2023 Results
4:17pm
8-K
GH
Guardant Health Inc
21 Dec 23
Guardant Health Announces $90.7 Million Registered Direct Offering with Baillie Gifford
4:07pm
8-K
4vactqww5
19 Dec 23
Guardant Health Announces Tentative Date of FDA Advisory Panel Review of Shield™ Blood Test
5:20pm
8-K
gmwuv5y
15 Nov 23
Other Events
6:04am
8-K
31q8lqnxeziz
6 Nov 23
Guardant Health Reports Third Quarter 2023 Financial Results and Increases Revenue Guidance
4:10pm
8-K
fkhbbe
3 Nov 23
Departure of Directors or Certain Officers
5:10pm
8-K
ewjv4t tt8cq
7 Sep 23
Regulation FD Disclosure
7:30am
8-K
oiz7 wnjqjl4hte0
3 Aug 23
Guardant Health Reports Second Quarter 2023 Financial Results and Increases Revenue Guidance
4:14pm
8-K
qjodyekl3nt0jx4grp8i
1 Aug 23
Guardant resolves pending litigation with Illumina and enters into new agreement to advance long-term commercial partnership and cancer research
4:15pm
8-K
lzz78
20 Jun 23
Submission of Matters to a Vote of Security Holders
4:08pm
8-K
j4t14n5gll3r68
25 May 23
Other Events
4:05pm
8-K
rnxvi4vh 0b0
9 May 23
Guardant Health Reports First Quarter 2023 Financial Results
4:13pm
8-K
w3nrhhdv
9 May 23
Guardant Health presents additional information from ECLIPSE study at 2023 Digestive Disease Week on the performance of Shield™ blood test
10:23am
8-K
gcr5qt
8 May 23
Guardant Health Announces Additions to Leadership Team
4:29pm
8-K
5ze2r
10 Apr 23
Changes in Registrant's Certifying Accountant
4:58pm
8-K
avi9sqcdn798d6nxp6
10 Mar 23
Regulation FD Disclosure
9:05pm
8-K
twso7tf
27 Feb 23
Musa Tariq joins Guardant Health board of directors
4:10pm